Logo image of APLT

APPLIED THERAPEUTICS INC (APLT) Stock Fundamental Analysis

NASDAQ:APLT - Nasdaq - US03828A1016 - Common Stock - Currency: USD

0.3861  -0.01 (-2.25%)

After market: 0.3901 +0 (+1.04%)

Fundamental Rating

2

Taking everything into account, APLT scores 2 out of 10 in our fundamental rating. APLT was compared to 559 industry peers in the Biotechnology industry. The financial health of APLT is average, but there are quite some concerns on its profitability. APLT is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

APLT had negative earnings in the past year.
APLT had a negative operating cash flow in the past year.
APLT had negative earnings in each of the past 5 years.
In the past 5 years APLT always reported negative operating cash flow.
APLT Yearly Net Income VS EBIT VS OCF VS FCFAPLT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 -20M -40M -60M -80M -100M

1.2 Ratios

With a Return On Assets value of -76.46%, APLT is not doing good in the industry: 68.34% of the companies in the same industry are doing better.
APLT's Return On Equity of -118.66% is in line compared to the rest of the industry. APLT outperforms 42.04% of its industry peers.
Industry RankSector Rank
ROA -76.46%
ROE -118.66%
ROIC N/A
ROA(3y)-185.04%
ROA(5y)-152.5%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
APLT Yearly ROA, ROE, ROICAPLT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2017 2018 2019 2020 2021 2022 2023 2024 0 500 -500 -1K -1.5K -2K

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for APLT so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
APLT Yearly Profit, Operating, Gross MarginsAPLT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 -5K -10K -15K -20K

More info and screens

5

2. Health

2.1 Basic Checks

Compared to 1 year ago, APLT has more shares outstanding
APLT has more shares outstanding than it did 5 years ago.
APLT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
APLT Yearly Shares OutstandingAPLT Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
APLT Yearly Total Debt VS Total AssetsAPLT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

2.2 Solvency

APLT has an Altman-Z score of -18.55. This is a bad value and indicates that APLT is not financially healthy and even has some risk of bankruptcy.
APLT has a worse Altman-Z score (-18.55) than 83.36% of its industry peers.
APLT has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -18.55
ROIC/WACCN/A
WACCN/A
APLT Yearly LT Debt VS Equity VS FCFAPLT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M

2.3 Liquidity

A Current Ratio of 3.00 indicates that APLT has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 3.00, APLT is doing worse than 65.12% of the companies in the same industry.
APLT has a Quick Ratio of 3.00. This indicates that APLT is financially healthy and has no problem in meeting its short term obligations.
APLT has a worse Quick ratio (3.00) than 63.69% of its industry peers.
Industry RankSector Rank
Current Ratio 3
Quick Ratio 3
APLT Yearly Current Assets VS Current LiabilitesAPLT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

More info and screens

3

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 84.86% over the past year.
Looking at the last year, APLT shows a very negative growth in Revenue. The Revenue has decreased by -97.39% in the last year.
EPS 1Y (TTM)84.86%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%77.61%
Revenue 1Y (TTM)-97.39%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-100%

3.2 Future

The Earnings Per Share is expected to grow by 14.58% on average over the next years. This is quite good.
The Revenue is expected to grow by 226.65% on average over the next years. This is a very strong growth
EPS Next Y14.58%
EPS Next 2Y18.89%
EPS Next 3Y16.77%
EPS Next 5Y14.58%
Revenue Next Year1406.93%
Revenue Next 2Y669.41%
Revenue Next 3Y406.87%
Revenue Next 5Y226.65%

3.3 Evolution

APLT Yearly Revenue VS EstimatesAPLT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 100M 200M 300M 400M 500M
APLT Yearly EPS VS EstimatesAPLT Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 -1 -2 -3 -4

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for APLT. In the last year negative earnings were reported.
Also next year APLT is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
APLT Price Earnings VS Forward Price EarningsAPLT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
APLT Per share dataAPLT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 -0.4 -0.6

4.3 Compensation for Growth

APLT's earnings are expected to grow with 16.77% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y18.89%
EPS Next 3Y16.77%

More info and screens

0

5. Dividend

5.1 Amount

APLT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

APPLIED THERAPEUTICS INC

NASDAQ:APLT (6/10/2025, 8:27:48 PM)

After market: 0.3901 +0 (+1.04%)

0.3861

-0.01 (-2.25%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)05-13 2025-05-13/amc
Earnings (Next)08-05 2025-08-05/bmo
Inst Owners106.55%
Inst Owner Change-6.92%
Ins Owners1.64%
Ins Owner Change14.74%
Market Cap54.66M
Analysts80
Price Target2.93 (658.87%)
Short Float %14.79%
Short Ratio8.2
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)152.44%
Min EPS beat(2)22.6%
Max EPS beat(2)282.27%
EPS beat(4)3
Avg EPS beat(4)54.75%
Min EPS beat(4)-197.84%
Max EPS beat(4)282.27%
EPS beat(8)3
Avg EPS beat(8)-31.7%
EPS beat(12)7
Avg EPS beat(12)-10.6%
EPS beat(16)10
Avg EPS beat(16)-5.63%
Revenue beat(2)0
Avg Revenue beat(2)-100%
Min Revenue beat(2)-100%
Max Revenue beat(2)-100%
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)-20.69%
EPS NQ rev (1m)9.09%
EPS NQ rev (3m)9.09%
EPS NY rev (1m)10.67%
EPS NY rev (3m)-33.15%
Revenue NQ rev (1m)3.66%
Revenue NQ rev (3m)3.66%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-40.35%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 205.5
P/FCF N/A
P/OCF N/A
P/B 1.49
P/tB 1.49
EV/EBITDA N/A
EPS(TTM)-0.28
EYN/A
EPS(NY)-0.47
Fwd EYN/A
FCF(TTM)-0.66
FCFYN/A
OCF(TTM)-0.66
OCFYN/A
SpS0
BVpS0.26
TBVpS0.26
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -76.46%
ROE -118.66%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-185.04%
ROA(5y)-152.5%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 3
Quick Ratio 3
Altman-Z -18.55
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)84.86%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%77.61%
EPS Next Y14.58%
EPS Next 2Y18.89%
EPS Next 3Y16.77%
EPS Next 5Y14.58%
Revenue 1Y (TTM)-97.39%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-100%
Revenue Next Year1406.93%
Revenue Next 2Y669.41%
Revenue Next 3Y406.87%
Revenue Next 5Y226.65%
EBIT growth 1Y8.1%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year36.26%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-54.99%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-54.99%
OCF growth 3YN/A
OCF growth 5YN/A